{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:19:30Z","timestamp":1779297570620,"version":"3.51.4"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470322"],"award-info":[{"award-number":["82470322"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Hyperthyroidism is a risk factor for atrial fibrillation (AF), and N6-methyladenosine (m6A) RNA methylation is crucial in cardiovascular regulation. However, the role of Fto-mediated m6A demethylation in hyperthyroidism-related AF remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We consecutively recruited 232 AF patients undergoing ablation, stratified into age-, gender-, and comorbidity-matched cohorts, 116 with manifest hyperthyroidism and 116 without manifest hyperthyroidism. Assessments included thyroid profiles, echocardiography, low-voltage area (LVA) mapping, and 1-year recurrence. T4-treated mice with cardiomyocyte-specific Fto knockout or AAV9-mediated Fto overexpression were used. Electrophysiological and structural properties were assessed via electrical mapping and echocardiography. Mechanisms were further investigated in neonatal rat atrial myocytes (NRAMs). The hyperthyroid group showed higher 1-year recurrence (19.8 vs. 5.2%, P &amp;lt; 0.001) and larger LVA (27.81 vs. 20.25%, P &amp;lt; 0.001). Hyperthyroidism independently predicted LVA expansion (odds ratio = 2.868, P &amp;lt; 0.001). In mice, Fto up-regulation increased atrial fibrosis and AF susceptibility, while its deletion attenuated T4-induced atrial fibrosis and AF. Wild-type Fto overexpression promoted AF via m6A-dependent enhancement of lysyl oxidase (Lox) expression. Studies in NRAMs demonstrated that Fto enhanced the transcription and translation of Lox by reducing m6A methylation on Lox mRNA. Lox inhibition with BAPN suppressed fibrosis and AF inducibility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hyperthyroidism promoted atrial arrhythmogenicity through Fto-mediated m6A demethylation of Lox, increasing Lox expression and atrial fibrosis. Targeting Fto-m6A-Lox may offer a novel therapy for hyperthyroidism-associated AF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/europace\/euag047","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:38:53Z","timestamp":1773146333000},"source":"Crossref","is-referenced-by-count":1,"title":["Fto-mediated m6A demethylation of Lox drives atrial fibrosis and promotes atrial fibrillation in a murine model of hyperthyroidism"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3372-2221","authenticated-orcid":false,"given":"Han","family":"Gong","sequence":"first","affiliation":[{"name":"Institute of Cardiovascular Diseases, The First Affiliated Hospital of Dalian Medical University , No. 222 Zhongshan Rd, Dalian ,","place":["China"]},{"name":"Department of Cardiology, The First Affiliated Hospital of Dalian Medical University , No. 222 Zhongshan Rd, Dalian ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Diseases, The First Affiliated Hospital of Dalian Medical University , No. 222 Zhongshan Rd, Dalian ,","place":["China"]},{"name":"Department of Cardiology, The First Affiliated Hospital of Dalian Medical University , No. 222 Zhongshan Rd, Dalian ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8972-1466","authenticated-orcid":false,"given":"Ruopeng","family":"Tan","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Diseases, The First Affiliated Hospital of Dalian Medical University , No. 222 Zhongshan Rd, Dalian ,","place":["China"]},{"name":"Department of Cardiology, The First Affiliated Hospital of Dalian Medical University , No. 222 Zhongshan Rd, Dalian ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1821-2316","authenticated-orcid":false,"given":"Lin","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Diseases, The First Affiliated Hospital of Dalian Medical University , No. 222 Zhongshan Rd, Dalian ,","place":["China"]},{"name":"Department of Cardiology, The First Affiliated Hospital of Dalian Medical University , No. 222 Zhongshan Rd, Dalian ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Su","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Diseases, The First Affiliated Hospital of Dalian Medical University , No. 222 Zhongshan Rd, Dalian ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Diseases, The First Affiliated Hospital of Dalian Medical University , No. 222 Zhongshan Rd, Dalian ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3565-893X","authenticated-orcid":false,"given":"Xiaomeng","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Dalian Medical University , No. 222 Zhongshan Rd, Dalian ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"2026042915015007700_euag047-B1","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1001\/jama.2023.19052","article-title":"Hyperthyroidism: a review","volume":"330","author":"Lee","year":"2023","journal-title":"JAMA"},{"key":"2026042915015007700_euag047-B2","doi-asserted-by":"crossref","first-page":"e230254","DOI":"10.1530\/ETJ-23-0254","article-title":"Epidemiology, prognosis, and challenges in the management of hyperthyroidism-related atrial fibrillation","volume":"13","author":"Kostopoulos","year":"2024","journal-title":"Eur Thyroid J"},{"key":"2026042915015007700_euag047-B3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"2026042915015007700_euag047-B4","first-page":"84","article-title":"Predictors of atrial fibrillation recurrence in hyperthyroid and euthyroid patients","volume":"106","author":"Gurdogan","year":"2016","journal-title":"Arq Bras Cardiol"},{"key":"2026042915015007700_euag047-B5","doi-asserted-by":"crossref","first-page":"4259183","DOI":"10.1155\/2017\/4259183","article-title":"Thyrotoxic atrial fibrillation: factors associated with persistence and risk of ischemic stroke","volume":"2017","author":"Wong","year":"2017","journal-title":"J Thyroid Res"},{"key":"2026042915015007700_euag047-B6","doi-asserted-by":"crossref","first-page":"H1448","DOI":"10.1152\/ajpheart.00828.2004","article-title":"Effects of hyperthyroidism on delayed rectifier K+ currents in left and right murine atria","volume":"289","author":"Hu","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026042915015007700_euag047-B7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00395-010-0149-5","article-title":"Molecular characterization of thyroid hormone-inhibited atrial L-type calcium channel expression: implication for atrial fibrillation in hyperthyroidism","volume":"106","author":"Chen","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"2026042915015007700_euag047-B8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0735-1097(01)01731-4","article-title":"Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes","volume":"39","author":"Chen","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026042915015007700_euag047-B9","first-page":"e24378","article-title":"Hyperthyroidism and the risk of cardiac arrhythmias: a narrative review","volume":"14","author":"Ahmad","year":"2022","journal-title":"Cureus"},{"key":"2026042915015007700_euag047-B10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.vph.2009.10.001","article-title":"Thyroid hormones and cardiac arrhythmias","volume":"52","author":"Tribulova","year":"2010","journal-title":"Vascul Pharmacol"},{"key":"2026042915015007700_euag047-B11","doi-asserted-by":"crossref","first-page":"100785","DOI":"10.1016\/j.lanepe.2023.100785","article-title":"Atrial fibrillation: pathophysiology, genetic and epigenetic mechanisms","volume":"37","author":"Vinciguerra","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"2026042915015007700_euag047-B12","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.3390\/ijms26115253","article-title":"Epigenetic drivers of atrial fibrillation: mechanisms, biomarkers, and therapeutic targets","volume":"26","author":"Karakasis","year":"2025","journal-title":"Int J Mol Sci"},{"key":"2026042915015007700_euag047-B13","doi-asserted-by":"crossref","first-page":"659628","DOI":"10.3389\/fcvm.2021.659628","article-title":"Role of N(6)-methyladenosine RNA modification in cardiovascular disease","volume":"8","author":"Song","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2026042915015007700_euag047-B14","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1093\/nar\/gkab378","article-title":"A comprehensive review of m6A\/m6Am RNA methyltransferase structures","volume":"49","author":"Oerum","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2026042915015007700_euag047-B15","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026042915015007700_euag047-B16","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2026042915015007700_euag047-B17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/eurheartj\/ehw260","article-title":"Catheter ablation in patients with persistent atrial fibrillation","volume":"38","author":"Kirchhof","year":"2017","journal-title":"Eur Heart J"},{"key":"2026042915015007700_euag047-B18","doi-asserted-by":"crossref","first-page":"e70263","DOI":"10.1111\/acel.70263","article-title":"The m6A demethylase Fto enhances susceptibility to atrial fibrillation by demethylating Kcne1 in aging mice","volume":"24","author":"Tan","year":"2025","journal-title":"Aging cell"},{"key":"2026042915015007700_euag047-B19","doi-asserted-by":"crossref","first-page":"euaf083","DOI":"10.1093\/europace\/euaf083","article-title":"GSTP1 inhibits angiotensin II-induced atrial fibrillation by regulating ferroptosis","volume":"27","author":"Li","year":"2025","journal-title":"Europace"},{"key":"2026042915015007700_euag047-B20","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.21037\/jtd-2025-1377","article-title":"Effect of aerobic exercise on the susceptibility of atrial fibrillation among aged mice","volume":"17","author":"Zhao","year":"2025","journal-title":"J Thorac Dis"},{"key":"2026042915015007700_euag047-B21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S2213-8587(23)00005-0","article-title":"Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis","volume":"11","author":"Wiersinga","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026042915015007700_euag047-B22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10840-007-9088-y","article-title":"Catheter ablation of atrial fibrillation in patients with hyperthyroidism","volume":"18","author":"Ma","year":"2007","journal-title":"J Interv Card Electrophysiol"},{"key":"2026042915015007700_euag047-B23","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.hrthm.2015.06.004","article-title":"History of hyperthyroidism and long-term outcome of catheter ablation of drug-refractory atrial fibrillation","volume":"12","author":"Wongcharoen","year":"2015","journal-title":"Heart Rhythm"},{"key":"2026042915015007700_euag047-B24","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/01.RES.0000096362.60730.AE","article-title":"Kv1.5 is an important component of repolarizing K+ current in canine atrial myocytes","volume":"93","author":"Fedida","year":"2003","journal-title":"Circ Res"},{"key":"2026042915015007700_euag047-B25","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/eurheartj\/ehs442","article-title":"Genetic variation in KCNA5: impact on the atrial-specific potassium current IKur in patients with lone atrial fibrillation","volume":"34","author":"Christophersen","year":"2013","journal-title":"Eur Heart J"},{"key":"2026042915015007700_euag047-B26","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/01.RES.85.6.498","article-title":"Thyroid hormone regulates hyperpolarization-activated cyclic nucleotide-gated channel (HCN2) mRNA in the rat heart","volume":"85","author":"Pachucki","year":"1999","journal-title":"Circ Res"},{"key":"2026042915015007700_euag047-B27","doi-asserted-by":"crossref","first-page":"159276","DOI":"10.1016\/j.bbalip.2022.159276","article-title":"RNA-seq reveals that anti-obesity irisin and triiodothyronine (T3) hormones differentially affect the purinergic signaling transcriptomics in differentiated human adipocytes","volume":"1868","author":"Mathias","year":"2023","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2026042915015007700_euag047-B28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41569-022-00759-w","article-title":"Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology","volume":"20","author":"Dobrev","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"2026042915015007700_euag047-B29","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1136\/heartjnl-2014-307398","article-title":"Incidence and prognostic significance of new onset atrial fibrillation\/flutter in acute pericarditis","volume":"101","author":"Imazio","year":"2015","journal-title":"Heart"},{"key":"2026042915015007700_euag047-B30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cardiores.2004.01.018","article-title":"The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model","volume":"62","author":"Kumagai","year":"2004","journal-title":"Cardiovasc Res"},{"key":"2026042915015007700_euag047-B31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.etap.2010.09.003","article-title":"Oxidative stress induced by thyroid dysfunction in rat erythrocytes and heart","volume":"31","author":"Messarah","year":"2011","journal-title":"Environ Toxicol Pharmacol"},{"key":"2026042915015007700_euag047-B32","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00018-005-5457-9","article-title":"Thyroid hormone-induced oxidative stress","volume":"63","author":"Venditti","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"2026042915015007700_euag047-B33","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","article-title":"Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"2026042915015007700_euag047-B34","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.3390\/biomedicines10081982","article-title":"Effect of hyperthyroidism treatments on heart rate variability: a systematic review and meta-analysis","volume":"10","author":"Brusseau","year":"2022","journal-title":"Biomedicines"},{"key":"2026042915015007700_euag047-B35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.autneu.2018.06.006","article-title":"Imbalance of cardiac autonomic nervous activity and increase of ventricular repolarization dynamicity induced by thyroid hormones in hyperthyroidism","volume":"213","author":"Cai","year":"2018","journal-title":"Auton Neurosci"},{"key":"2026042915015007700_euag047-B36","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s13075-014-0504-2","article-title":"The sympathetic nervous response in inflammation","volume":"16","author":"Pongratz","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2026042915015007700_euag047-B37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/HYPERTENSIONAHA.109.142646","article-title":"Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system","volume":"55","author":"Lob","year":"2010","journal-title":"Hypertension"},{"key":"2026042915015007700_euag047-B38","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/eurheartj\/ehz786","article-title":"Atrial fibrillation and cardiac fibrosis","volume":"41","author":"Sohns","year":"2020","journal-title":"Eur Heart J"},{"key":"2026042915015007700_euag047-B39","doi-asserted-by":"crossref","first-page":"14654","DOI":"10.1038\/s41598-022-18860-y","article-title":"Sacubitril\/valsartan (LCZ696) ameliorates hyperthyroid-induced cardiac hypertrophy in male rats through modulation of miR-377, let-7 b, autophagy, and fibrotic signaling pathways","volume":"12","author":"Khamis","year":"2022","journal-title":"Sci Rep"},{"key":"2026042915015007700_euag047-B40","doi-asserted-by":"crossref","first-page":"euaf021","DOI":"10.1093\/europace\/euaf021","article-title":"Decreased METTL3 in atrial myocytes promotes atrial fibrillation","volume":"27","author":"Shi","year":"2025","journal-title":"Europace"},{"key":"2026042915015007700_euag047-B41","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1093\/eurheartj\/ehaf130","article-title":"SLC31A1 loss depletes mitochondrial copper and promotes cardiac fibrosis","volume":"46","author":"Tu","year":"2025","journal-title":"Eur Heart J"},{"key":"2026042915015007700_euag047-B42","doi-asserted-by":"crossref","first-page":"55801","DOI":"10.1074\/jbc.M410124200","article-title":"Thyroxine-thyroid hormone receptor interactions","volume":"279","author":"Sandler","year":"2004","journal-title":"J Biol Chem"},{"key":"2026042915015007700_euag047-B43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","article-title":"Thyroid hormones and cardiovascular disease","volume":"14","author":"Jabbar","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2026042915015007700_euag047-B44","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.jacc.2018.02.045","article-title":"Thyroid hormones and cardiovascular function and diseases","volume":"71","author":"Razvi","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026042915015007700_euag047-B45","doi-asserted-by":"crossref","first-page":"13021","DOI":"10.1016\/S0021-9258(18)99978-3","article-title":"Delineation of three different thyroid hormone-response elements in promoter of rat sarcoplasmic reticulum Ca2+ATPase gene. Demonstration that retinoid X receptor binds 5\u02b9 to thyroid hormone receptor in response element 1","volume":"269","author":"Hartong","year":"1994","journal-title":"J Biol Chem"},{"key":"2026042915015007700_euag047-B46","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.yjmcc.2018.09.010","article-title":"Converse role of class I and class IIa HDACs in the progression of atrial fibrillation","volume":"125","author":"Zhang","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"2026042915015007700_euag047-B47","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cvr\/cvv265","article-title":"Keeping up the balance: role of HDACs in cardiac proteostasis and therapeutic implications for atrial fibrillation","volume":"109","author":"Zhang","year":"2016","journal-title":"Cardiovasc Res"},{"key":"2026042915015007700_euag047-B48","doi-asserted-by":"crossref","first-page":"118459","DOI":"10.1016\/j.bbamcr.2019.03.006","article-title":"Role of HDACs in cardiac electropathology: therapeutic implications for atrial fibrillation","volume":"1867","author":"Brundel","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2026042915015007700_euag047-B49","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejphar.2016.04.034","article-title":"Targeting histone deacetylases: a novel therapeutic strategy for atrial fibrillation","volume":"781","author":"Lkhagva","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"2026042915015007700_euag047-B50","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.yjmcc.2008.08.015","article-title":"Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin","volume":"45","author":"Liu","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"2026042915015007700_euag047-B51","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/CIRCULATIONAHA.113.005300","article-title":"Activation of histone deacetylase-6 induces contractile dysfunction through derailment of \u03b1-tubulin proteostasis in experimental and human atrial fibrillation","volume":"129","author":"Zhang","year":"2014","journal-title":"Circulation"},{"key":"2026042915015007700_euag047-B52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00395-021-00855-x","article-title":"Epigenetic regulation of cardiac electrophysiology in atrial fibrillation: HDAC2 determines action potential duration and suppresses NRSF in cardiomyocytes","volume":"116","author":"Lugenbiel","year":"2021","journal-title":"Basic Res Cardiol"},{"key":"2026042915015007700_euag047-B53","doi-asserted-by":"crossref","first-page":"e007071","DOI":"10.1161\/CIRCEP.118.007071","article-title":"HDAC (histone deacetylase) inhibitor valproic acid attenuates atrial remodeling and delays the onset of atrial fibrillation in mice","volume":"12","author":"Scholz","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026042915015007700_euag047-B54","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s12272-020-01297-0","article-title":"Therapeutic effects of histone deacetylase inhibitors on heart disease","volume":"43","author":"Chun","year":"2020","journal-title":"Arch Pharm Res"},{"key":"2026042915015007700_euag047-B55","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/HYPERTENSIONAHA.110.154567","article-title":"HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats","volume":"56","author":"Cardinale","year":"2010","journal-title":"Hypertension"},{"key":"2026042915015007700_euag047-B56","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41420-022-00926-5","article-title":"METTL3 stabilizes HDAC5 mRNA in an m(6)A-dependent manner to facilitate malignant proliferation of osteosarcoma cells","volume":"8","author":"Jiang","year":"2022","journal-title":"Cell Death Discov"},{"key":"2026042915015007700_euag047-B57","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1038\/s41388-025-03473-2","article-title":"K88 acetylation of FTO increases its RNA m(6)A demethylation and promotes tumorigenesis","volume":"44","author":"Li","year":"2025","journal-title":"Oncogene"},{"key":"2026042915015007700_euag047-B58","first-page":"1820","article-title":"Role of the lysyl oxidase enzyme family in cardiac function and disease","volume":"115","author":"Al-U'datt","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2026042915015007700_euag047-B59","first-page":"8","article-title":"The role of lysyl oxidase enzymes in cardiac function and remodeling","volume":"9","author":"Rodr\u00edguez","year":"2019","journal-title":"Cells"},{"key":"2026042915015007700_euag047-B60","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1096\/fj.201601157RR","article-title":"Lysyl oxidase overexpression accelerates cardiac remodeling and aggravates angiotensin II-induced hypertrophy","volume":"31","author":"Galan","year":"2017","journal-title":"FASEB J"},{"key":"2026042915015007700_euag047-B61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1167\/iovs.65.13.33","article-title":"Role of lysyl oxidase-like protein 3 in the pathogenesis of Graves\u2019 orbitopathy in orbital fibroblasts","volume":"65","author":"Park","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2026042915015007700_euag047-B62","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.yjmcc.2010.12.019","article-title":"Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation","volume":"50","author":"Adam","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"2026042915015007700_euag047-B63","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/CIRCULATIONAHA.123.065874","article-title":"Frequent premature atrial contractions lead to adverse atrial remodeling and atrial fibrillation in a swine model","volume":"149","author":"Higuchi","year":"2024","journal-title":"Circulation"},{"key":"2026042915015007700_euag047-B64","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.yjmcc.2015.05.019","article-title":"Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice","volume":"85","author":"Adam","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"2026042915015007700_euag047-B65","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jare.2023.01.018","article-title":"Single-cell analysis reveals lysyl oxidase (Lox)(+) fibroblast subset involved in cardiac fibrosis of diabetic mice","volume":"54","author":"Li","year":"2023","journal-title":"J Adv Res"},{"key":"2026042915015007700_euag047-B66","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/ATVBAHA.123.320402","article-title":"\u03b2-Aminopropionitrile induces distinct pathologies in the ascending and descending thoracic aortic regions of mice","volume":"44","author":"Franklin","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026042915015007700_euag047-B67","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1161\/HYPERTENSIONAHA.109.140558","article-title":"Pharmacologically induced thoracic and abdominal aortic aneurysms in mice","volume":"55","author":"Kanematsu","year":"2010","journal-title":"Hypertension"},{"key":"2026042915015007700_euag047-B68","doi-asserted-by":"crossref","first-page":"euae204","DOI":"10.1093\/europace\/euae204","article-title":"Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)","volume":"26","author":"Goette","year":"2024","journal-title":"Europace"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euag047\/67302835\/euag047.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/4\/euag047\/67302835\/euag047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/4\/euag047\/67302835\/euag047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:02:10Z","timestamp":1777489330000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euag047\/8514526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3,30]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euag047","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,11]]},"article-number":"euag047"}}